Kalaris Therapeutics, Inc. (KLRS) — Cash Flow Reinvestment Rate
Latest as of December 2018:
0.00x
Kalaris Therapeutics, Inc. (KLRS) has a Cash Flow Reinvestment Rate of 0.00x as of December 2018, reinvesting $0.00 (capex $0.00 ) from operating cash flow of $1.94 Million. See KLRS net asset quality score to measure how much of total assets are equity-financed.
Reinvestment Rate
0.00x
(Capex + Investments) / Operating CF
Total Reinvested
$0.00
Capex + Investments
Operating Cash Flow
$1.94 Million
USD
Capital Expenditures
$0.00
USD
Kalaris Therapeutics, Inc. Cash Flow Reinvestment Rate (2018–2018)
Historical reinvestment intensity for Kalaris Therapeutics, Inc. across 1 annual periods. Also explore Kalaris Therapeutics, Inc. assets under control for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Kalaris Therapeutics, Inc. (2018–2018)
Year-by-year capital reinvestment analysis for Kalaris Therapeutics, Inc.. For live market cap and broader valuation context, see KLRS market cap overview.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2018 | 0.00x | $0.00 | $1.94 Million | $0.00 | — |
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow